NZ717927A - Compositions for the treatment of hypertension and/or fibrosis - Google Patents
Compositions for the treatment of hypertension and/or fibrosisInfo
- Publication number
- NZ717927A NZ717927A NZ717927A NZ71792714A NZ717927A NZ 717927 A NZ717927 A NZ 717927A NZ 717927 A NZ717927 A NZ 717927A NZ 71792714 A NZ71792714 A NZ 71792714A NZ 717927 A NZ717927 A NZ 717927A
- Authority
- NZ
- New Zealand
- Prior art keywords
- fibrosis
- hypertension
- treatment
- compositions
- prophylactic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/09—Geometrical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2013903573A AU2013903573A0 (en) | 2013-09-17 | Compositions for the treatment of hypertension and/or fibrosis | |
| PCT/AU2014/000923 WO2015039173A1 (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ717927A true NZ717927A (en) | 2018-12-21 |
Family
ID=52687998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ717927A NZ717927A (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US9458093B2 (enExample) |
| EP (1) | EP3046901B1 (enExample) |
| JP (1) | JP6122548B2 (enExample) |
| KR (1) | KR101736416B1 (enExample) |
| CN (1) | CN105683152B (enExample) |
| AP (1) | AP2016009079A0 (enExample) |
| AU (1) | AU2014324078B2 (enExample) |
| BR (1) | BR112016005601B1 (enExample) |
| CA (1) | CA2924356C (enExample) |
| DK (1) | DK3046901T3 (enExample) |
| ES (1) | ES2655455T3 (enExample) |
| IL (1) | IL244621A (enExample) |
| MX (1) | MX368865B (enExample) |
| MY (1) | MY172557A (enExample) |
| NO (1) | NO3046901T3 (enExample) |
| NZ (1) | NZ717927A (enExample) |
| PH (1) | PH12016500497B1 (enExample) |
| PL (1) | PL3046901T3 (enExample) |
| RU (1) | RU2635564C2 (enExample) |
| SG (1) | SG11201601642WA (enExample) |
| UA (1) | UA118111C2 (enExample) |
| WO (1) | WO2015039173A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3284981B2 (ja) | 1998-11-02 | 2002-05-27 | 株式会社デンソー | 車両用交流発電機およびそのステータの製造方法 |
| US9956166B2 (en) | 2013-09-18 | 2018-05-01 | Sorrento Therapeutics, Inc. | Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin |
| SG11201707561RA (en) * | 2015-03-18 | 2017-10-30 | Vectus Biosystems Ltd | Compositions for the treatment of fibrosis and fibrosis-related conditions |
| NZ736165A (en) * | 2015-03-18 | 2022-07-01 | Vectus Biosystems Ltd | Compositions for the treatment of kidney and/or liver disease |
| EP3353147B1 (en) * | 2015-09-22 | 2021-01-13 | Vectus Biosystems Limited | Synthesis of terphenyl compounds |
| CN120114438A (zh) * | 2016-04-13 | 2025-06-10 | 内布拉斯加大学董事会 | 施用树脂毒素的方法和用树脂毒素治疗心血管疾病的方法 |
| BR112019001510B1 (pt) | 2016-07-28 | 2022-11-08 | Vectus Biosystems Limited | Composto, e, uso de um composto para manufatura de um medicamento para tratar profilática ou terapeuticamente fibrose pulmonar, ou uma enfermidade relacionada em um indivíduo com fibrose pulmonar ou em risco de desenvolver fibrose pulmonar |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2694288B1 (fr) * | 1992-06-30 | 1994-09-09 | Rhone Poulenc Agrochimie | Phenylbenzamides fongicides et procédés pour les préparer. |
| EP1768689B1 (en) * | 2004-06-11 | 2014-08-20 | Vectus Biosystems Limited | Compositions and methods for treatment of cardiovascular disease |
| AU2006322656B2 (en) * | 2005-12-09 | 2012-03-08 | Vectus Biosystems Limited | VIP fragments and methods of use |
| US20120088737A2 (en) * | 2009-10-02 | 2012-04-12 | Ajinomoto Co., Inc | Novel acyl guanidine derivatives |
| US9630935B2 (en) * | 2013-09-17 | 2017-04-25 | Vectus Biosystems Limited | Compositions for the treatment of hypertension and/or fibrosis |
-
2014
- 2014-09-17 MX MX2016003371A patent/MX368865B/es active IP Right Grant
- 2014-09-17 UA UAA201602267A patent/UA118111C2/uk unknown
- 2014-09-17 AU AU2014324078A patent/AU2014324078B2/en active Active
- 2014-09-17 BR BR112016005601-9A patent/BR112016005601B1/pt active IP Right Grant
- 2014-09-17 ES ES14845373.1T patent/ES2655455T3/es active Active
- 2014-09-17 JP JP2016515425A patent/JP6122548B2/ja active Active
- 2014-09-17 DK DK14845373.1T patent/DK3046901T3/en active
- 2014-09-17 CA CA2924356A patent/CA2924356C/en active Active
- 2014-09-17 CN CN201480050979.1A patent/CN105683152B/zh active Active
- 2014-09-17 RU RU2016112257A patent/RU2635564C2/ru active
- 2014-09-17 SG SG11201601642WA patent/SG11201601642WA/en unknown
- 2014-09-17 US US15/022,278 patent/US9458093B2/en active Active
- 2014-09-17 MY MYPI2016000482A patent/MY172557A/en unknown
- 2014-09-17 WO PCT/AU2014/000923 patent/WO2015039173A1/en not_active Ceased
- 2014-09-17 NZ NZ717927A patent/NZ717927A/en unknown
- 2014-09-17 PL PL14845373T patent/PL3046901T3/pl unknown
- 2014-09-17 EP EP14845373.1A patent/EP3046901B1/en active Active
- 2014-09-17 AP AP2016009079A patent/AP2016009079A0/xx unknown
- 2014-09-17 KR KR1020167008664A patent/KR101736416B1/ko active Active
- 2014-09-17 NO NO14845373A patent/NO3046901T3/no unknown
-
2016
- 2016-03-14 PH PH12016500497A patent/PH12016500497B1/en unknown
- 2016-03-16 IL IL244621A patent/IL244621A/en active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015010921A (es) | Compuestos de carbazol utiles como inhibidores de bromodominio. | |
| MY176489A (en) | Novel tricyclic compounds as anticancer agents | |
| MX2020001756A (es) | Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos. | |
| MY172578A (en) | Oral dosing of glp-1 compounds | |
| PH12016500497A1 (en) | Compositions for the treatment of hypertension and/or fibrosis | |
| PH12016500495A1 (en) | Compositions for the treatment of hypertension and/or fibrosis | |
| PH12016501122A1 (en) | Delayed release compositions of linaclotide | |
| UA118670C2 (uk) | Способи та композиції для загоєння ран | |
| PH12017500836A1 (en) | Transdermal formulations | |
| MX2014005510A (es) | Nuevas composiciones, produccion de las mismas y uso de las mismas para la produccion de poliamidas coladas. | |
| PH12017500348B1 (en) | Tetrahydroquinoline derivatives as bromodomain inhibitors | |
| MY182818A (en) | Compositions for the treatment of fibrosis and fibrosis-related conditions | |
| UA117567C2 (uk) | Композиція, яка стимулює лактацію, на основі фосфатидилсерину | |
| GEP20207145B (en) | Combination of trazodone and gabapentin for the treatmen | |
| MX2013008559A (es) | Derivados de leptina. | |
| AU2013903571A0 (en) | Compositions for the treatment of hypertension and/or fibrosis | |
| AU2013903572A0 (en) | Compositions for the treatment of hypertension and/or fibrosis | |
| AU2013903573A0 (en) | Compositions for the treatment of hypertension and/or fibrosis | |
| IN2013CH05770A (enExample) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 17 SEP 2020 BY DENNEMEYER + CO Effective date: 20190829 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 17 SEP 2021 BY DENNEMEYER + CO. Effective date: 20200907 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 17 SEP 2022 BY DENNEMEYER + CO Effective date: 20210911 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 17 SEP 2023 BY DENNEMEYER + CO. S.A.R.L. Effective date: 20220905 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 17 SEP 2024 BY DENNEMEYER + CO. S.A.R.L. Effective date: 20230904 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 17 SEP 2025 BY DENNEMEYER + CO. S.A.R.L. Effective date: 20240909 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 17 SEP 2026 BY DENNEMEYER + CO. SARL Effective date: 20260302 |